2021 -now Member, Tau Consortium Scientific Advisoy Board @
Beth Hoffman Education
The Johns Hopkins University
Ph.D. (Molecular Pharmacology, Cell Biology)
1983-1988
Wellesley College
A.B. (Molecular Biology)
1975-1979
Beth Hoffman Skills
Drug Development
Drug Discovery
Biotechnology
Neuroscience
Pharmacology
Lifesciences
Molecular Biology
Technology Transfer
Pharmaceutical Industry
Biopharmaceuticals
Stem Cell Technology
Stem Cell Research
Biomarkers
Biochemistry
3D Human Cell Models
Orphan Diseases
Cystic Fibrosis
Respiratory Disease
Liver Disease
Life Sciences
CRO
Clinical Development
Commercialization
Infectious Diseases
Immunology
Analytical Chemistry
Oncology
Cancer
Phenotypic Screening Technologies
Huntington's disease
CRO Management
Marketing
Business Strategy
Microsoft Excel
Leadership
Cell Culture
Project Management
Teaching
Fact Checking
Social Media
Public Speaking
Proofreading
Web Content
Blogging
Freelance Writing
Legal Writing
Digital Marketing
Advertising
Creative Writing
Facebook
Microsoft Office
Nonprofits
Dooh
Digital Signage
Editing
Online Research
Non Profits
Research
Copy Editing
Copywriting
Content Writing
Beth Hoffman Summary
Beth Hoffman, based in San Diego, CA, US, is currently a CEO at Origami Therapeutics, Inc.. Beth Hoffman brings experience from previous roles at Vertex Pharmaceuticals, Inc., Amgen, Inc., Eli Lilly & Co and National Institute of Mental Health. Beth Hoffman holds a 1983 - 1988 Ph.D. in Molecular Pharmacology, Cell Biology @ The Johns Hopkins University. With a robust skill set that includes Drug Development, Drug Discovery, Biotechnology, Neuroscience, Pharmacology and more. Beth Hoffman has 4 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Beth Hoffman?
Find contact details for 700 million professionals.